An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin

An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin

To assess the urodynamic changes in men with lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction treated with doxazosin and to correlate these changes with voiding symptoms. Fifty patients with LUTS were treated with doxazosin at a dose of 4 mg/day for 3 months. All men were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 1996-06, Vol.47 (6), p.840-844
Hauptverfasser: Gerber, Glenn S., Kim, Jae H., Contreras, Barbara A., Steinberg, Gary D., Rukstalis, Daniel B.
Format: Artikel
Sprache:eng
Schlagworte:
Adrenergic alpha-Antagonists - pharmacology
Adrenergic alpha-Antagonists - therapeutic use
Aged
Aged, 80 and over
Biological and medical sciences
Doxazosin - pharmacology
Doxazosin - therapeutic use
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Prostatic Hyperplasia - complications
Prostatic Hyperplasia - drug therapy
Urinary Bladder Neck Obstruction - drug therapy
Urinary Bladder Neck Obstruction - etiology
Urinary Bladder Neck Obstruction - physiopathology
Urinary system
Urodynamics - drug effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To assess the urodynamic changes in men with lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction treated with doxazosin and to correlate these changes with voiding symptoms. Fifty patients with LUTS were treated with doxazosin at a dose of 4 mg/day for 3 months. All men were initially evaluated by International Prostate Symptom Score (I-PSS) questionnaires, measurement of urinary flow rate and complex urodynamic study. Those patients completing the 3-month study underwent repeat testing. Forty-four (88%) men underwent initial and follow-up urodynamic evaluation. The mean I-PSS improved from 20.6 to 10.6 ( P
ISSN:0090-4295
1527-9995
DOI:10.1016/S0090-4295(96)00040-4